{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:23:41Z","timestamp":1785529421771,"version":"3.56.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.beem.2020.101399","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T12:20:38Z","timestamp":1582633238000},"page":"101399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The spectrum of low-renin hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Fabrizio","family":"Buffolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Pecori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Losano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cavagli\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Tetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2020.101399_bib1","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A\u00a0call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension","volume":"388","author":"Olsen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101399_bib2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101399_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2020.101399_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cen.13741","article-title":"Diagnostic approach to low-renin hypertension","volume":"89","author":"Monticone","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib6","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2020.101399_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.HYP.1.5.468","article-title":"Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences","volume":"1","author":"Gillum","year":"1979","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2020.101399_bib10","first-page":"221","article-title":"Renin activity in blood from patients with hypertension","volume":"90","author":"Helmer","year":"1964","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.beem.2020.101399_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0002-9343(72)90160-X","article-title":"The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension","volume":"53","author":"Laragh","year":"1972","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.1016\/j.beem.2020.101399_bib12","first-page":"177","article-title":"The meaning of aldosteronism in hypertensive disease","volume":"21","author":"Ledingham","year":"1967","journal-title":"Circ Res"},{"key":"10.1016\/j.beem.2020.101399_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197203022860901","article-title":"Essential hypertension: renin and aldosterone, heart attack and stroke","volume":"286","author":"Brunner","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2020.101399_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0002-9149(73)80047-5","article-title":"Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone","volume":"32","author":"B\u00fchler","year":"1973","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.beem.2020.101399_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/cs0640273","article-title":"The epidemiology of plasma renin","volume":"64","author":"Meade","year":"1983","journal-title":"Clin Sci"},{"key":"10.1016\/j.beem.2020.101399_bib16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(74)92211-9","article-title":"Disturbed relationship of plasma-renin to blood-pressure in hypertension","volume":"304","author":"Lucas","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101399_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1974.47","article-title":"Low-renin hypertension","volume":"5","author":"Dunn","year":"1974","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2020.101399_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0035-1548868","article-title":"Renin and aldosterone measurements in the management of arterial hypertension","volume":"47","author":"Viola","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2020.101399_bib20","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib21","first-page":"29","article-title":"Inhibition of RAS in diabetic nephropathy","volume":"8","author":"Yacoub","year":"2015","journal-title":"Int J Nephrol Renovascular Dis"},{"key":"10.1016\/j.beem.2020.101399_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030812","article-title":"Liddle syndrome: review of the literature and description of a new case","volume":"19","author":"Tetti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2020.101399_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jsbmb.2016.03.010","article-title":"Apparent mineralocorticoid excess","volume":"165","author":"Funder","year":"2017","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.beem.2020.101399_bib24","doi-asserted-by":"crossref","first-page":"E1933","DOI":"10.1073\/pnas.1621082114","article-title":"Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency","volume":"114","author":"Khattab","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2020.101399_bib25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/en.2002-220708","article-title":"The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related","volume":"144","author":"Rafestin-Oblin","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2020.101399_bib26","first-page":"683","article-title":"Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene","volume":"76","author":"Karl","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib27","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/HYPERTENSIONAHA.113.02187","article-title":"Pseudohypoaldosteronism type II: history, arguments, answers, and still some questions","volume":"63","author":"Healy","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020546","article-title":"The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor","volume":"19","author":"Baudrand","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2020.101399_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MED.0000000000000408","article-title":"Primary aldosteronism in the primary care setting","volume":"25","author":"Buffolo","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2020.101399_bib30","series-title":"Guideline: sodium intake for adults and children","year":"2012"},{"key":"10.1016\/j.beem.2020.101399_bib31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ajh\/hpt139","article-title":"Normal range of human dietary sodium intake: a perspective based on 24-hour urinary sodium excretion worldwide","volume":"26","author":"McCarron","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ajh.2011.210","article-title":"Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (cochrane review)","volume":"25","author":"Graudal","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijcard.2016.04.109","article-title":"Effect of sodium intake on renin level: analysis of general population and meta-analysis of randomized controlled trials","volume":"215","author":"Rhee","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.beem.2020.101399_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.CIR.52.1.146","article-title":"Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a \u201cno-salt\u201d culture","volume":"52","author":"Oliver","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2020.101399_bib35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2020.101399_bib36","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(97)07306-6","article-title":"Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London","volume":"351","author":"Baker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2020.101399_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.jhh.1001182","article-title":"T594M and G442V polymorphisms of the sodium channel beta subunit and hypertension in a black population","volume":"15","author":"Dong","year":"2001","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00004872-200305000-00016","article-title":"A\u00a0new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension","volume":"21","author":"Rayner","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib39","doi-asserted-by":"crossref","first-page":"10200","DOI":"10.1073\/pnas.95.17.10200","article-title":"A\u00a0genetic defect resulting in mild low-renin hypertension","volume":"95","author":"Wilson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2020.101399_bib40","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.amjhyper.2005.02.020","article-title":"Analysis of the 11 beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension","volume":"18","author":"Mariniello","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib41","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ajh\/hps080","article-title":"Age-related changes in 11\u03b2-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects","volume":"26","author":"Campino","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib42","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41588-018-0297-3","article-title":"Publisher correction: genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2020.101399_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2016.09.003","article-title":"Regulation of zonation and homeostasis in the adrenal cortex","volume":"441","author":"Pignatti","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib44","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1210\/jc.2009-2010","article-title":"Adrenocortical zonation in humans under normal and pathological conditions","volume":"95","author":"Nishimoto","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2020.101399_bib46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib47","first-page":"40","article-title":"Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"174","author":"Ishidoya","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.beem.2020.101399_bib48","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"72","author":"Meyer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib49","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2020.101399_bib50","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrendo.2012.230","article-title":"Role of KCNJ5 in familial and sporadic primary aldosteronism","volume":"9","author":"Mulatero","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/jhh.2017.34","article-title":"Familial hyperaldosteronism type III","volume":"31","author":"Monticone","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib53","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A\u00a0meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ans.12470","article-title":"Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism","volume":"85","author":"Ip","year":"2015","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.beem.2020.101399_bib55","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/HJH.0000000000001578","article-title":"KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma","volume":"36","author":"Kitamoto","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib56","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1210\/jc.2019-00531","article-title":"KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism","volume":"104","author":"Vilela","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib58","first-page":"1182","article-title":"Histopathological classification of cross-sectional image-negative hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","article-title":"Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas","volume":"63","author":"Williams","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2016.10.014","article-title":"Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism","volume":"441","author":"Nishimoto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib62","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2020.101399_bib63","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib64","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2020.101399_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib66","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","author":"Ito","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.beem.2020.101399_bib68","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/jc.2012-3353","article-title":"Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension","volume":"98","author":"Markou","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"key":"10.1016\/j.beem.2020.101399_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2265.2008.03213.x","article-title":"Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases","volume":"69","author":"M\u00e9deau","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2020.101399_bib70","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.beem.2011.11.006","article-title":"Subclinical primary aldosteronism","volume":"26","author":"Ito","year":"2012","journal-title":"Best Pract & Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101399_bib71","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/HYPERTENSIONAHA.111.00662","article-title":"Abnormal aldosterone physiology and cardiometabolic risk factors","volume":"61","author":"Vaidya","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2020.101399_bib73","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2020.101399_bib74","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ajh\/hpz023","article-title":"The aldosterone\/renin ratio predicts cardiometabolic disorders in subjects without classic primary aldosteronism","volume":"32","author":"Vecchiola","year":"2019","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2020.101399_bib75","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"J\u00a0Hypertens"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:46Z","timestamp":1761497806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X20300269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1521690X20300269"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2020.101399","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of low-renin hypertension","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2020.101399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101399"}}